tetano
Editor, Senior Moderator
Pharmacol Rep
. 2022 Aug 5.
doi: 10.1007/s43440-022-00398-5. Online ahead of print.
Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein
Deisy Segura-Villalobos[SUP] 1 [/SUP], Daniela Roa-Velázquez[SUP] 2 [/SUP], Dan I Zavala-Vargas[SUP] 2 [/SUP], Jessica G Filisola-Villaseñor[SUP] 2 [/SUP], Jorge Ivan Castillo Arellano[SUP] 3 [/SUP], Edgar Morales Ríos[SUP] 2 [/SUP], Ricardo Reyes-Chilpa[SUP] 4 [/SUP], Claudia González-Espinosa[SUP] 5 [/SUP]
Affiliations
Abstract
Background: COVID-19, the disease caused by SARS-CoV-2 virus infection, has been a major public health problem worldwide in the last 2 years. SARS-CoV-2-dependent activation of innate immune receptors contributes to the strong local and systemic inflammatory reaction associated with rapid disease evolution. The receptor-binding domain (RBD) of Spike (S) viral protein (S-RBD) is essential for virus infection and its interacting molecules in target cells are still under identification. On the other hand, the search for accessible natural molecules with potential therapeutic use has been intense and remains an active field of investigation.
Methods: C57BL6/J (control) and Toll-like receptor (TLR) 4-deficient (Lps del) mice were nebulized with recombinant S-RBD. Tumor Necrosis Factor-alpha (TNF-α) and Interleukin (IL)-6 production in bronchoalveolar lavages (BALs) was determined by enzyme-linked immunosorbent assay (ELISA). Lung-infiltrating cells recovered in BALs were quantified by hematoxylin-eosin (H&E) stain. In selected groups of animals, the natural compound Jacareubin or dexamethasone were intraperitoneally (ip) administered 2 hours before nebulization.
Results: A rapid lung production of TNF-α and IL-6 and cell infiltration was induced by S-RBD nebulization in control but not in Lps del mice. Pre-treatment with Jacareubin or dexamethasone prevented S-RBD-induced TNF-α and IL-6 secretion in BALs from control animals.
Conclusions: S-RBD domain promotes lung TNF-α and IL-6 production in a TLR4-dependent fashion in C57BL6/J mice. Xanthone Jacareubin possesses potential anti-COVID-19 properties that, together with the previously tested anti-inflammatory activity, safety, and tolerance, make it a valuable drug to be further investigated for the treatment of cytokine production caused by SARS-CoV-2 infection.
Keywords: Coronavirus; Lung inflammation; RBD; Spike protein; TLR4.
. 2022 Aug 5.
doi: 10.1007/s43440-022-00398-5. Online ahead of print.
Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein
Deisy Segura-Villalobos[SUP] 1 [/SUP], Daniela Roa-Velázquez[SUP] 2 [/SUP], Dan I Zavala-Vargas[SUP] 2 [/SUP], Jessica G Filisola-Villaseñor[SUP] 2 [/SUP], Jorge Ivan Castillo Arellano[SUP] 3 [/SUP], Edgar Morales Ríos[SUP] 2 [/SUP], Ricardo Reyes-Chilpa[SUP] 4 [/SUP], Claudia González-Espinosa[SUP] 5 [/SUP]
Affiliations
- PMID: 35930194
- DOI: 10.1007/s43440-022-00398-5
Abstract
Background: COVID-19, the disease caused by SARS-CoV-2 virus infection, has been a major public health problem worldwide in the last 2 years. SARS-CoV-2-dependent activation of innate immune receptors contributes to the strong local and systemic inflammatory reaction associated with rapid disease evolution. The receptor-binding domain (RBD) of Spike (S) viral protein (S-RBD) is essential for virus infection and its interacting molecules in target cells are still under identification. On the other hand, the search for accessible natural molecules with potential therapeutic use has been intense and remains an active field of investigation.
Methods: C57BL6/J (control) and Toll-like receptor (TLR) 4-deficient (Lps del) mice were nebulized with recombinant S-RBD. Tumor Necrosis Factor-alpha (TNF-α) and Interleukin (IL)-6 production in bronchoalveolar lavages (BALs) was determined by enzyme-linked immunosorbent assay (ELISA). Lung-infiltrating cells recovered in BALs were quantified by hematoxylin-eosin (H&E) stain. In selected groups of animals, the natural compound Jacareubin or dexamethasone were intraperitoneally (ip) administered 2 hours before nebulization.
Results: A rapid lung production of TNF-α and IL-6 and cell infiltration was induced by S-RBD nebulization in control but not in Lps del mice. Pre-treatment with Jacareubin or dexamethasone prevented S-RBD-induced TNF-α and IL-6 secretion in BALs from control animals.
Conclusions: S-RBD domain promotes lung TNF-α and IL-6 production in a TLR4-dependent fashion in C57BL6/J mice. Xanthone Jacareubin possesses potential anti-COVID-19 properties that, together with the previously tested anti-inflammatory activity, safety, and tolerance, make it a valuable drug to be further investigated for the treatment of cytokine production caused by SARS-CoV-2 infection.
Keywords: Coronavirus; Lung inflammation; RBD; Spike protein; TLR4.